Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2009-07-14
2011-12-20
Kim, Young J (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
08080378
ABSTRACT:
A method for detecting colon cancer by detecting COX-2 from a human feces sample or detecting COX-2 RNA from a human feces sample.
REFERENCES:
patent: 4843155 (1989-06-01), Chomczynski
patent: 5654179 (1997-08-01), Lin
patent: 5777099 (1998-07-01), Mehra
patent: 6258541 (2001-07-01), Chapkin et al.
patent: 6329179 (2001-12-01), Kopreski
patent: 6406857 (2002-06-01), Shuber et al.
patent: 7101663 (2006-09-01), Godfrey et al.
patent: 7378239 (2008-05-01), Dieckmann et al.
patent: 7833757 (2010-11-01), Steinberg et al.
patent: 7939255 (2011-05-01), Chung
patent: 0 389 063 (1990-09-01), None
patent: 1 674 869 (2006-06-01), None
patent: 2002-142767 (2002-05-01), None
patent: WO 00/63358 (2000-10-01), None
patent: WO 2005/019827 (2005-03-01), None
patent: WO 2007/018257 (2007-02-01), None
Ioannidis et al., “Replication validity of genetic association studies,” Nature Genetics, Nov. 2001, vol. 29, pp. 306-309.
Wacholder et al., “Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies,” Journal of National Cancer Institute, Mar. 17, 2004, vol. 96, No. 6, pp. 434-442.
Leung et al., “Detection of Hypermethylated DNA or Cyclooxygenase-2 Messenger RNA in Fecal Samples of Patients With Colorectal Cancer or Polyps,” The American Journal of Gastroenterology, May 2007, vol. 102, pp. 1070-1076 (Abstract Only).
L.A. Davidson et al., “Non-invasive detection of fecal protein kinase C βIIand ç messenger RNA: putative biomarkers for colon cancer,” Carcinogenesis, vol. 19, No. 2, (1998), pp. 253 to 257.
T. Yamao et al., “Abnormal Expression of CD44 Variants in the Exfoliated Cells in the Feces of Patients With Colorectal Cancer,” Gastroenterology, vol. 114, No. 6, (1998), pp. 1196 to 1205.
R.L. Alexander et al., “Purification of Total RNA from Human Stool Samples,” Digestive Diseases and Sciences, vol. 43, No. 12, (Dec. 1998), pp. 2652 to 2658.
Hajime Sano et al., “Expression of Cyclooxygenase-1 and -2 in Human Colorectal Cancer,” Cancer Research, vol. 55, No. 17, (1995), pp. 3785 to 3789.
S. Kanaoka et al., “Shou P-379 Potential of colorectal cancer screening by using RT-PCR method in which COX-2 from feces is used as a marker,” Japanese Journal of Gastroenterology, vol. 99, special extra issue, Sep. 20, 2002, p. A634 Sho P-379.
H. Sano et al., Expression of Cyclooxygenase-1 and -2 in Human Colorectal Cancer,Cancer Research, 55, (Sep. 1, 1995), pp. 3785-3789.
Ultrapsec™-II RNA, Biotecx Bulletin No. 28, (1993).
D. Sidransky et al., “Identification ofrasOncogene Mutations in the Stool of Patients with Curable Colorectal tumors,”Science, 256, Apr. 3, 1992, 102-105.
S.M. Dong et al., “Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targts,”Journal of the National Cancer Institute, 93(11), Jun. 6, 2001, 858-865.
G. Traverso et al., “Detection ofAPCMutations in Fecal DNA From Patients With Colorectal Tumors,”The New England Journal of Medicine, 346(5), Jan. 31, 2002, 311-320.
G. Traverso et al., “Detection of Proximal Colorectal Cancers Through Analysis of Faecal DNA,”The Lancet, 359, Feb. 2, 2002, 403-404.
Fang Sheng, Wu Pei, Liu Yongzhong, et al., “Clinical Investigation of Expression of Gastrin mRNA in Colorectal Carcinoma,”Proceedings of Wannan Medical College, vol. 21, (2002), 20-23.
Rainer Deuter et al., “A method for preparation of fecal DNA suitble for PCR,”Nucleic Acids Research, 1995, vol. 23, No. 18, pp. 3800 to 3801.
Lagerholm et al., COX-2 Expression in Fecal Colonocytes from Patients with Inflammatory Bowel Disease (IBD),Gastroenterology, vol. 120, No. 5, Supplement 1, Abstract No. 16, (Apr. 2001) p. A-4.
Kanaoka S. et al., “Potential Usefulness of Detecting Cyclooxygenase 2 Messenger RNA in Feces for Colorectal Cancer Screening,”Gastroenterology, (2004), vol. 147, No. 2, pp. 422-427.
Nosho K. et al., “Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis,”Carcinogenesis, (2005), vol. 26, No. 5, pp. 892-899.
Boedefeld W.M. et al., “Increased expression of E1A-F, MMP-7, and COX-2 in human colorectal cancer,”Proceedings of the American Association for Cancer Research Annual Meeting, (2002), vol. 43, p. 730, #3623.
Li X. et al., “Co-Expression of Matrix Metalloproteinase-7 and Cyclooxygenase-2 in Human Colorectal Carcinoma,”Proceedings of the American Association for Cancer Research Annual Meeting, (2002), vol. 42 , p. 614, #3302.
De Craene B. et al., “The Transcription Factor Snail Induces Tumor Cell Invasion through Modulation of the Epithelial Cell Differentiation Program,”Cancer Research, (2005), vol. 65, No. 14, pp. 6237-6244.
Roy H.K. et al., “The Transcriptional Repressor SNAIL is Overexpressed in Human Colon Cancer,”Digestive Diseases and Sciences, (2005), vol. 50, No. 1, pp. 42-46.
Dutta S.K. et al., “Noninvasive Detection of Colorectal Cancer by Molecular tools: Coming of Age,”Gastroenterology, (1998), vol. 114, No. 6, pp. 1333-1335.
Kanemoto S. et al., “Funbenchu no COX-2 mRNA o Hyoteki ni shita DaichoganShindan Kenshin no Kanosei ni Tsuite,”Nippon Shokaki Shudan Kenshin Gakkai Zasshi, (2004), vol. 42, No. 2, p. 58 (S3-3).
Michael Okimoto, Ambion's Poly(A) Pure mRNA Isolation Kit, Aug. 25, 2000.
Shattuck-Brandt, R.L. et al., “Differential Expression of Matrilysin and Cyclooxygenase-2- in Intestinal and Colorectal Neoplasms,”Molecular Carcinogenesis, 1999, vol. 24, No. 3, 1999, pp. 177-187.
Kanaoka Shigeru et al., “RNA-based stool assay is superior to a single immunochemical fecal occult blood test for detecting early colorectal cancer and adenoma,”Gastroenterology, vol. 130, No. 4, Suppl. 2, Apr. 2006, p. A471, Digestive Disease Week Meeting/107th Annual Meeting of the American-Gastroenterological-Association; Los Angeles, CA, USA, May 19-24, 2006.
Takai Tetsunari et al., “Potential usefulness of detecting cyclooxygenase 2 and matrix metalloproteinase 7 messenger RNA in feces for colorectal cancer screening,”Gastroenterology, vol. 130, No. 4, Suppl. 2, Apr. 2006, p. A188, Digestive Disease Week Meeting/107th Annual Meeting of the American-Gastroenterological-Association, Los Angeles, CA, USA, May 19-24, 2006.
Kanaoka Shigeru et al., “A comparison of fecal RNA test with immunochemical fecal occult blood test for detecting colorectal cancer and adenoma,”Gastroenterology, vol. 132, No. 4, Suppl. 2, Apr. 2007, p. A623, Digestive Week Meeting/108th Annual Meeting of the American-Gastroenterological-Association, Washington, DC., USA, May 19-24, 2007.
Kanaoka Shigeru et al., Potential usefulness of predicting stage of colorectal cancer by fecal RNA testGastroenterology, vol. 134, No. 4, Suppl. 1, Apr. 2008, p. A183, Digestive Disease Week Meeting/109th Annual Meeting of the American-Gastroenterological-Association, San Diego, CA, USA, May 17-22, 2008.
Murphy et al. entitled “Gene expression studies using microarrays: principles, problems, and prospects,” (Adv Physiol Educ. Dec. 2002; 26(1-4):256-70).
Lucentini, who entitled an article, “Gene Association Studies Typically Wrong” (The Scientist, 18(24):20).
Grigoryev et al. (Genome Biol. 2004;5(5):R34. Epub Apr. 27, 2004).
European Examination Report dated Mar. 5, 2010, issued for corresponding European Patent Application 06 782 598.4.
Arimura, Yoshiaki et al.; “Special Topic: Colonic Cancer and Ulcerative Colitis, Practice of Diagnosis of Colonic Cancer—Clinical Tests”; Clinics and Researches, vol. 75, No. 8, Aug. 1998, Article Serial No. 0004, pp. 1697-1699.
Japanese Office Action dated Apr. 26, 2011, issued in corresponding Japanese Patent Application No. 2007-529617.
Kawamata,Hitoshi et al.; “COX-2 and Colorectal
Hamamatsu Foundation for Science and Technology Promotion
Kim Young J
Olympus Corporation
Westerman Hattori Daniels & Adrian LLP
LandOfFree
Method of detecting colon cancer marker does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of detecting colon cancer marker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting colon cancer marker will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4257885